Glaxo Operations UK Ltd. v. Quigg
District Court, E.D. Virginia
1Opinion of the Court
MEMORANDUM OPINION
ELLIS, District Judge.
Introduction 1
In this suit for declaratory and injunctive relief, plaintiff, the holder of a patent for an orally-administered antibiotic drug, challenges the denial of its application for a patent term extension pursuant to the Drug Price Competition and Patent Restoration Act of 1984 (the “Act”). 2 Title II of the Act, 35 U.S.C. § 156, permits extensions of the patent term for certain patented new drugs required to undergo the Food and Drug Administration’s (FDA) rigorous and often time-consuming new drug approval procedures. Such procedures often…
2Cases cited17 opinions
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- United States v. TurketteSupreme Court of the United States · 1981
- Consumer Product Safety Commission v. GTE Sylvania, Inc.Supreme Court of the United States · 1980
- Vermont Yankee Nuclear Power Corp. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1978
12 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- Glaxo Operations Uk Limited v. Donald J. Quigg, Assistant Secretary of Commerce and Commissioner of Patents and TrademarksCourt of Appeals for the Federal Circuit · 1990
- Abbott Laboratories v. Frank D. Young, Dr., Commissioner, Food and Drug AdministrationCourt of Appeals for the D.C. Circuit · 1990
- Hoechst-Roussel Pharmaceuticals, Inc. v. LehmanCourt of Appeals for the Federal Circuit · 1997
- Angiotech Pharmaceuticals Inc. v. LeeDistrict Court, E.D. Virginia · 2016
- PHOTOCURE ASA v. DudasDistrict Court, E.D. Virginia · 2009
5 more not listed; retrieve them via the Exa API.